ClinicalTrials.Veeva

Menu

Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials

P

Power Life Sciences

Status

Not yet enrolling

Conditions

Breast Cancer
Triple Negative Breast Cancer

Study type

Observational

Funder types

Industry

Identifiers

NCT05769491
84434789

Details and patient eligibility

About

Clinical trials can sometimes favor certain demographic groups. Additionally, there is limited research that delves into the factors that influence participation in clinical trials, both positive and negative.

The goal is to identify the obstacles and challenges that prevent participation in Triple Negative Breast Cancer clinical trials, as well as the reasons for withdrawal or discontinuation.

The insights gained from this study will ultimately benefit those with Triple Negative Breast Cancer who may be invited to participate in clinical research in the years to come.

Enrollment

500 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
  • Capable of giving signed informed consent, which includes compliance with requirements and restrictions listed in the informed consent form (ICF) and in the protocol

Exclusion criteria

  • Pregnant or lactating woman
  • Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
  • Inability to perform regular electronic reporting

Trial design

Trial documents
1

Trial contacts and locations

0

Loading...

Central trial contact

Michael B Gill

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems